Nektar Therapeutics (formerly Inhale Therapeutic Systems, Shearwater, and Bradford Particle Design) is a pioneer and leader in advanced drug delivery technologies that enable highly differentiated products. Our goal is to help our pharmaceutical and biotechnology partners realize the full potential of their molecules by solving complex development challenges to create breakthrough therapeutics, extend product franchises, and fuel product pipelines.
Through our broad scientific and development expertise and our suite of proprietary technologies, Nektar has helped companies such as Pfizer, Roche, Chiron, and Amgen improve drug performance and optimize the delivery of their products either by creating new products or extending product lifecycles. By providing the technologies and expertise to potentially make drugs safer, more effective, and easier to administer, our advanced drug delivery solutions can help our partners create better therapies for patients and achieve greater commercial success.
